Susquehanna International Group, LLP Acurx Pharmaceuticals, Inc. Put Options Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
Put Options
1 transactions
Others Institutions Holding ACXP
# of Institutions
27Shares Held
1.99MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$5.66 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$768,6210.0% of portfolio
-
Morgan Stanley New York, NY106KShares$557,5550.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.8KShares$460,8500.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.85KShares$446,2500.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $60.7M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...